Bigul

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate Tablets
20-10-2020

Zydus Cadila gets tentative USFDA nod for generic drug

The company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version of Pfizer''s Xeljanz XR tablets, Zydus Cadila said in a statement.
19-10-2020
Bigul

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Cadila receives tentative approval from USFDA for Tofacitinib Extended-Release Tablets
19-10-2020

Zydus Cadila gets USFDA nod for generic drugs

The company has received final approval from the US Food and Drug Administration (USFDA) for the medication in 300 mg strength, Zydus Cadila said in a statement.
17-10-2020
Bigul

CADILA HEALTHCARE LTD. - 532321 - Statement Of Investor Complaints For The Quarter Ended September 2020

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dhaval N SoniDesignation :- Company Secretary and Compliance Officer
17-10-2020
Bigul

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Cadila receives Final Approval from USFDA for Ursodiol Capsules and Tentative Approval for Linagliptin and Metformin Hydrochloride Tablets
17-10-2020

Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection

Fingolimod capsules is indicated for the treatment of patients with relapsing forms of multiple sclerosis. While, Verapamil Hydrochloride Injection, is used to rapidly/temporarily restore normal heartbeats in people with certain heart rhythm disorders.
16-10-2020
Bigul

CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release on Fingolimod Capsules and Verapamil Hydrochloride Injection
16-10-2020
Bigul

Indian samples of global Covid-19 vaccines need to be larger: Experts

Indian players like Bharat Biotech and Zydus Cadila ready for large-scale phase-3 trials
13-10-2020
Bigul

CADILA HEALTHCARE LTD. - 532321 - Compliance Certificate Under Regulation 40(10)

Compliance Certificate under regulation 40(10) of the SEBI Listing Regulations, 2015
12-10-2020
Next Page
Close

Let's Open Free Demat Account